Head-to-head · computed 2026-08-11
Eden vs MEDVi
Eden: Eden attaches a $99/month membership to tiered medication pricing; all-in figures land at $198 semaglutide and $408 tirzepatide at maintenance. MEDVi: MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat.
Tirzepatide
| Eden | MEDVi | |
|---|---|---|
| All-in maintenance | $408/mo | $399/mo |
| Best plan rate | $408/mo | $399/mo |
| 12-month total | $4,896 | $4,788 |
| Status | Provider-stated · 2026-08-05 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, MEDVi's $399 a month undercuts Eden's $408 by $9 a month at the 10 mg/wk maintenance basis — $108 across a year. MEDVi's figure is provider-stated (captured 2026-08-05) and Eden's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Eden's tirzepatide ladder runs $408 a month billed monthly. MEDVi's runs $399 a month billed monthly. On the twelve-month basis MEDVi's $4,788 beats Eden's $4,896 by $108 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| Eden | MEDVi | |
|---|---|---|
| All-in maintenance | $198/mo | $299/mo |
| Best plan rate | $198/mo | $299/mo |
| 12-month total | $2,376 | $3,588 |
| Status | Provider-stated · 2026-08-05 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, Eden's $198 a month undercuts MEDVi's $299 by $101 a month at the 2.4 mg/wk maintenance basis — $1,212 across a year. Eden's figure is provider-stated (captured 2026-08-05) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Eden's semaglutide ladder runs $198 a month billed monthly. MEDVi's runs $299 a month billed monthly. On the twelve-month basis Eden's $2,376 beats MEDVi's $3,588 by $1,212 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
MEDVi carries no membership fee against Eden's $99 a month — $1,188 a year of structural cost before any medication ships, which is why this site prices everything all-in. On dose economics, MEDVi is dose-flat — the price survives titration — while Eden's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
Eden
- Membership$99/mo
- Dose policyTiered on tirzepatide
- CommitmentMonth-to-month
- CancellationCancel anytime
- PharmacyPartner pharmacies
MEDVi
- MembershipNone
- Dose policyTiered on semaglutide; tirzepatide flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
What our desk is watching on each
Eden: Membership plus dose tiering makes Eden's advertised numbers diverge sharply from all-in cost. Open conflict on record: a third-party read of Eden's live treatment page dated July 9, 2026 computed $298/mo all-in tirzepatide ($199 medication + $99 membership) under a new 'Same Price at Every Dose' structure, while our August 5 capture recorded $408 all-in — Eden ran at least three distinct rate structures between April and July 2026, so both figures may have been true on their dates. Flagged for priority re-capture; the later first-party capture stands until then.
MEDVi: Start-vs-maintenance spread on semaglutide; compare on maintenance.
Questions people ask
Is Eden or MEDVi cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Eden vs MEDVi miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Eden and MEDVi cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,896 at Eden and $4,788 at MEDVi — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Eden · MEDVi. Official sites: Eden ↗ · MEDVi ↗. Nothing here is medical advice.